Pfizer seeking emergency use of its COVID-19 vaccine in US

Coronavirus

FILE – In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (AP Photo/Bebeto Matthews, File)

Pfizer is set to ask U.S. regulators to allow emergency use of its COVID-19 vaccine, starting a process that could bring first shots as early as next month.

Friday’s step comes days after Pfizer and its German partner BioNTech announced its vaccine appears 95% protective in a large but not yet finished study. Over the next few weeks, the Food and Drug Administration and its scientific advisers will have to decide if there’s really enough evidence to allow emergency vaccinations.

If so, first supplies will be scarce and rationed. Experts warn it likely will be spring before there’s enough for everyone. 

© 2020 Associated Press. All Rights Reserved. Material may not be redistributed.

Copyright 2020 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Continuing The Conversation
See Full Weather Forecast

Trending Stories

Don't Miss!

More Don't Miss

Your Guide To
Coronavirus

KELOLAND News is covering the Coronavirus outbreak. We have created a guide to everything you need to know to prepare. We also have the latest stories from across the globe feeding into this page.


 

More Contests